We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
S-1 and Gemcitabine as an Outpatient-based Regimen in Patients with Advanced or Metastatic Pancreatic Cancer.
- Authors
Kim, Min Kyoung; Lee, Kyung Hee; Jang, Byung Ik; Kim, Tae Nyeun; Eun, Jong Ryul; Bae, Sung Hwa; Ryoo, Hun Mo; Lee, Sun Ah; Hyun, Myung Soo
- Abstract
Objective: The standard beneficial chemotherapy proved for patients with pancreatic cancer is a regimen containing gemcitabine. Novel oral fluoropyrimidine, S-1, can be added to gemcitabine to improve the efficacy of chemotherapy and to provide better convenience for patients. We aimed to evaluate the efficacy and safety of S-1 plus gemcitabine combination chemotherapy as a first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
- Publication
Japanese Journal of Clinical Oncology, 2009, Vol 39, Issue 1, p49
- ISSN
0368-2811
- Publication type
Article